Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 61,256 shares at $26.19 ($1.6M) on 2018-01-17, disclosed to the SEC on 2018-01-18.
Open-market sale of $1.6M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.19 | 23,726 | $621K | 38.2% |
| 2 | $26.84 | 37,530 | $1.0M | 61.8% |
| Total | $26.59 avg | 61,256 | $1.6M | 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |